GGrantIndex
← Leaderboards

Patrick Joseph Brennan

Colorado State University-Fort Collins

Google Scholar ↗PubMed ↗ORCID ↗
$8,803,724
Attributed
$8,803,724
Total exposure
9
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.7M · FY2005–09
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09

Funding mix

By agency

NIH$10,973,248 · 10

By mechanism

R01$4,961,563 · 4
R37$2,715,853 · 1
P01$2,397,542 · 3
U54$790,670 · 1
R03$107,620 · 1

Top collaborators

No co-investigators on record.

Most similar at Colorado State University-Fort Collins

Same institution · by research overlap

Others in their field

Top investigators on “Drug Discovery /Isolation”

Research focus

Drug Discovery /IsolationCell WallMycobacterium TuberculosisAntitubercular AgentsMolecular CloningEnzyme ActivityProtein Structure FunctionPhenotypeMycobacterium LepraeEpidemiologyPeptidoglycanDrug Design /Synthesis /ProductionGenotypeLeprosyGene TargetingMembrane BiogenesisGlycosyltransferaseBaseIsoprenoidCellsChemical Structure FunctionGuinea PigsBacterial PolysaccharidesCommunicable Disease Diagnosis

Grant awards (36)

Leprosy Bacillus: From Genotype to Phenotype to Tools$327,285
R01 · FY2009 · AI · contact PI
Leprosy Bacillus: From Genotype to Phenotype to Tools$317,752
R01 · FY2008 · AI · contact PI
MYCOBACTERIAL CELL WALL AND DRUG DISCOVERY$343,715
R37 · FY2007 · AI · contact PI
Product Development and Manufacturing (PDM) Core$323,112
U54 · FY2007 · AI · contact PI
Leprosy Bacillus: From Genotype to Phenotype to Tools$315,781
R01 · FY2007 · AI · contact PI
Biogenesis of lipoarabinomannan in mycobacteria$356,888
R01 · FY2006 · AI · contact PI
MYCOBACTERIAL CELL WALL AND DRUG DISCOVERY$353,981
R37 · FY2006 · AI · contact PI
Leprosy Bacillus: From Genotype to Phenotype to Tools$347,008
R01 · FY2006 · AI · contact PI
Identification of Desaturase Targets$301,250
R01 · FY2006 · AI · contact PI
Product Development and Manufacturing (PDM) Core$229,639
U54 · FY2006 · AI · contact PI
LEPROSY BACILLUS,: FROM GENOTYPE TO PHENOTYPE$396,855
R01 · FY2005 · AI
MYCOBACTERIAL CELL WALL AND DRUG DISCOVERY$362,500
R37 · FY2005 · AI
Biogenesis of lipoarabinomannan in mycobacteria$347,423
R01 · FY2005 · AI
Identification of Desaturase Targets$324,250
R01 · FY2005 · AI
Product Development and Manufacturing (PDM) Core$237,919
U54 · FY2005 · AI
M. tuberculosis Cell Wall Biogenesis;New Drugs;TB-HIV$34,560
R03 · FY2005 · TW
LEPROSY BACILLUS,: FROM GENOTYPE TO PHENOTYPE$386,836
R01 · FY2004 · AI
MYCOBACTERIAL CELL WALL AND DRUG DISCOVERY$362,500
R37 · FY2004 · AI
M. tuberculosis Cell Wall Biogenesis;New Drugs;TB-HIV$34,560
R03 · FY2004 · TW
MYCOBACTERIAL CELL WALL AND DRUG DISCOVERY$412,500
R37 · FY2003 · AI
LEPROSY BACILLUS,: FROM GENOTYPE TO PHENOTYPE$377,100
R01 · FY2003 · AI
M. tuberculosis Cell Wall Biogenesis;New Drugs;TB-HIV$38,500
R03 · FY2003 · TW
CELL WALL OF M TUBERCULOSIS: FOCUS FOR DRUG DISCOVERY$745,284
P01 · FY2002 · AI
MYOCOBACTERIAL CELL WALL AND DRUG DISCOVERY$446,835
R37 · FY2002 · AI
LEPROSY BACILLUS,: FROM GENOTYPE TO PHENOTYPE$367,633
R01 · FY2002 · AI
CORE--CHEMICAL SYNTHESIS SUPPORT FACILITY$0
P01 · FY2002 · AI
DRUGS CONTRADICTING FATTY ACID AND MYCOLIC ACID SYNTHESIS$0
P01 · FY2002 · AI
CELL WALL OF M TUBERCULOSIS: FOCUS FOR DRUG DISCOVERY$722,338
P01 · FY2001 · AI
MYOCOBACTERIAL CELL WALL AND DRUG DISCOVERY$433,822
R37 · FY2001 · AI
LEPROSY BACILLUS,: FROM GENOTYPE TO PHENOTYPE$374,316
R01 · FY2001 · AI
CORE--CHEMICAL SYNTHESIS SUPPORT FACILITY$0
P01 · FY2001 · AI
DRUGS CONTRADICTING FATTY ACID AND MYCOLIC ACID SYNTHESIS$0
P01 · FY2001 · AI
CELL WALL OF M TUBERCULOSIS: FOCUS FOR DRUG DISCOVERY$701,902
P01 · FY2000 · AI
MYOCOBACTERIAL CELL WALL AND DRUG DISCOVERY$421,186
R01 · FY2000 · AI
CORE--CHEMICAL SYNTHESIS SUPPORT FACILITY$114,010
P01 · FY2000 · AI
DRUGS CONTRADICTING FATTY ACID AND MYCOLIC ACID SYNTHESIS$114,008
P01 · FY2000 · AI